Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Cara Therapeutics (CARA) has a market cap of $24.332 million USD. According to our data, Cara Therapeutics is ranked No.8470 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $24.33 M |
-13.03%
|
| Dec 31, 2024 | $27.98 M |
-31.36%
|
| Dec 29, 2023 | $40.76 M |
-93.08%
|
| Dec 30, 2022 | $0.59 B |
-11.82%
|
| Dec 31, 2021 | $0.67 B |
-19.50%
|
| Dec 31, 2020 | $0.83 B |
-6.08%
|
| Dec 31, 2019 | $0.88 B |
23.92%
|
| Dec 31, 2018 | $0.71 B |
6.21%
|
| Dec 29, 2017 | $0.67 B |
31.75%
|
| Dec 30, 2016 | $0.51 B |
-44.90%
|
| Dec 31, 2015 | $0.92 B |
69.11%
|
| Dec 31, 2014 | $0.55 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Incyte
INCY
|
$11.31 B |
0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
Ireland
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Nektar Therapeutics
NKTR
|
$0.12 B |
0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
USA
|
 ACADIA Pharmaceuticals
ACAD
|
$2.50 B |
-0.000 M
|
USA
|
| Market Cap | = | CARA Stock Price | * | CARA Shares Outstanding |
| = | $5.32 | * | 4.57 M | |
| = | $24.33 M |